Clozapine is an FDA-approved atypical antipsychotic drug for treatment-resistant schizophrenia.

Clozapine was first synthesized in 1956 in many European countries like Switzerland, Austria, West Germany, and Finland.

**Other Advantages**

- Lower risk of suicide (clozapine hasÂ been shown to reduce suicidal behavior even in patients with non-treatment-resistant schizophrenia and schizoaffective disorder.)

- Lower risk for tardive dyskinesia

- Improvement of cognition which leads to improved quality of life

- Decreased relapse